Soluble Programmed Death Receptor Ligands sPD-L1 and sPD-L2 as Liquid Biopsy Markers for Prognosis and Platinum Response in Epithelial Ovarian Cancer

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.01015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Role of Soluble Programmed Death-1 (sPD-1) and sPD-ligand 1 in Patients With Cystic Echinococcosis

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2015English

Programmed Death Ligand 1 (PD-L1) Expression in Epithelial Ovarian Cancer: A Comparison of Type I and Type II Tumors

Asian Pacific Journal of Cancer Prevention
2019English

Induction of FGF Receptor 2-IIIb Expression and Response to Its Ligands in Epithelial Ovarian Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2001English

Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors

Frontiers in Oncology
Cancer ResearchOncology
2019English

Soluble VEGF Receptor 1 (sFLT1) Induces Non-Apoptotic Death in Ovarian and Colorectal Cancer Cells

Scientific Reports
Multidisciplinary
2016English

Der Aufbruch Der Frauen in Der SPD

2019English

The Prognostic Role of Immune Checkpoint Markers Programmed Cell Death Protein 1 (PD-1) and Programmed Death Ligand 1 (PD-L1) in a Large, Multicenter Prostate Cancer Cohort

Oncotarget
Oncology
2017English

Elevated Serum Soluble Programmed Cell Death Ligand 1 Concentration as a Potential Marker for Poor Prognosis in Small Cell Lung Cancer Patients With Chemotherapy

Respiratory Research
PulmonaryRespiratory Medicine
2018English

Engineering Interface Structures and Thermal Stabilities via SPD Processing in Bulk Nanostructured Metals

Scientific Reports
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy